Amortized Payments For High-Cost Drugs Won't Work, Insurer CEOs Say

The idea raised by health policy experts that high-cost drugs could be paid for in installments over a number of years doesn't appeal to insurance executives at recent conference.

More from Market Access

More from Pink Sheet